The outcome of the recent mid-term elections in the USA surprised many by returning a Democrat-led Senate, preventing Republicans from gaining control of the ne 28 November 2022
The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) for moderately to severely active ulcerative colitis (UC) whe 25 November 2022
The British reimbursement agency, the National Institute for Health and Care Excellence (NICE), has provided a positive recommendation for an Opdivo (nivolumab) 25 November 2022
In a landmark regulatory first, Dutch gene therapy company uniQure (Nasdaq: QURE) has secured approval for its one-time hemophilia B treatment, Hemgenix (etrana 23 November 2022
In a draft recommendation, the UK’s reimbursement agency has found in favor of three COVID-19 treatments, while sidelining several others. 16 November 2022
Boston, USA-based pricing watchdog The Institute for Clinical and Economic Review (ICER) has published an evidence report on the comparative clinical effectiven 2 November 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.